Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Laryngol Otol ; 118(11): 857-61, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15638971

RESUMEN

A growing body of evidence suggests that a variety of upper respiratory symptoms (URS) are associated with gastro-oesophageal reflux (GORD). The aim of this study was to determine the prevalence of endoscopic erosive, and non-erosive, oesophagitis among patients complaining of persistent URS, in the absence of typical GORD symptoms, and to compare them with a comparison group of similar age. A group of 110 patients aged 18-75, presenting with persistent URS with no suspicion of GORD symptoms, underwent upper flexible endoscopy, with biopsy sampling for histology, and was compared with a group of 117 patients of similar age undergoing endoscopy for reasons other than GORD. Patients affected with upper airway disorders, such as posterior laryngitis, chronic sinusitis and vocal fold nodules, had a significantly higher prevalence of oesophagitis of varying degrees (31 per cent) compared to the comparison population (15.4 per cent) (p < 0.01). These data suggest that in many patients with chronic URS occult gastro-oesophageal diseases are present.


Asunto(s)
Esofagitis/complicaciones , Reflujo Gastroesofágico/complicaciones , Enfermedades Respiratorias/etiología , Adolescente , Adulto , Anciano , Enfermedad Crónica , Esofagitis/diagnóstico , Esofagitis/epidemiología , Esofagoscopía , Femenino , Reflujo Gastroesofágico/diagnóstico , Humanos , Enfermedades de la Laringe/etiología , Masculino , Persona de Mediana Edad , Prevalencia , Sinusitis/etiología
2.
Digestion ; 66(3): 154-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12481161

RESUMEN

BACKGROUND: Rabeprazole has been demonstrated to be a potent antisecretory agent and has been shown to be clinically effective in the treatment of acid-related diseases. AIMS: It was to determine the efficacy of rabeprazole at 20 and 40 mg in addition to amoxicillin and clarithromycin in the treatment of active Helicobacter pylori-positive duodenal ulcers compared with omeprazole 40 mg. PATIENTS AND METHODS: One hundred and twenty-seven patients were randomised into three treatment groups: 40 patients were treated with rabeprazole 40 mg daily, 42 patients with rabeprazole 20 mg daily and 45 patients with omeprazole 40 mg daily for 10 days. All patients received amoxicillin 1 g twice a day and clarithromycin 500 mg twice a day for 5 days. All patients were re-assessed at least 4 weeks after the end of the treatment. RESULTS: According to the intention-to-treat (ITT) protocol, ulcer healing was observed in 90% of patients in the rabeprazole 40 group, in 85.7% in the rabeprazole 20 group and in 93.3% in the omeprazole 40 group. We observed H. pylori eradication in 90% ITT in the rabeprazole 40 group, in 80.9% ITT in the rabeprazole 20 group and in 88.8% ITT in the omeprazole 40 group. Statistical analysis did not show significant differences among the three groups. CONCLUSIONS: A 10-day rabeprazole 20 mg regimen represents an efficacious and safe regimen for H. pylori eradication and ulcer healing.


Asunto(s)
Antiulcerosos/uso terapéutico , Bencimidazoles/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Omeprazol/uso terapéutico , 2-Piridinilmetilsulfinilbencimidazoles , Adulto , Amoxicilina/uso terapéutico , Claritromicina/uso terapéutico , Esquema de Medicación , Quimioterapia Combinada , Femenino , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Humanos , Masculino , Cooperación del Paciente , Estudios Prospectivos , ATPasas de Translocación de Protón/uso terapéutico , Rabeprazol
3.
Am J Physiol Lung Cell Mol Physiol ; 283(6): L1291-302, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12424147

RESUMEN

We investigated the effect of altered extracellular pH, mitochondrial function, and ATP content on development of apoptosis in human pulmonary artery endothelial cells after treatment with staurosporine (STS). STS produced a concentration- and time-dependent increase in caspase-3 activity in pH 7.4 medium that reached a peak at 6 h. The increase in caspase activity was associated with significant DNA fragmentation. Fluorescent imaging of treated monolayers in pH 7.4 medium with Hoechst-33342-propidium iodide demonstrated a large percentage of apoptotic cells ( approximately 40%) with no evidence of necrosis. Caspase activity, DNA fragmentation, and percentage of apoptotic cells were reduced after STS treatment in acidic media (pH 7.0 and 6.6). The Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-AM inhibited STS-induced apoptosis, whereas the rise in intracellular Ca2+concentration in STS-treated cells in pH 7.4 medium was reduced in pH 7.0 medium. These results suggest that one mechanism for inhibitory effects of acidosis may be a pH-induced alteration in Ca2+ signaling. Treatment with STS in the presence of oligomycin (10 microM), an inhibitor of the mitochondrial F(0)F(1)-ATPase, in glucose-free media abolished caspase activation and DNA fragmentation in association with severe ATP depletion ( approximately 2% of control cells). Imaging demonstrated a change in the mode of cell death from apoptosis to necrosis under these conditions. This change was linked to the level of ATP depletion, because STS treatment in the absence of glucose or the presence of oligomycin in media with glucose still leads to apoptosis in the presence of only moderate ATP depletion. These results demonstrate that pH, mitochondrial function, and ATP supply are important variables that regulate STS-induced apoptosis in human pulmonary artery endothelial cells.


Asunto(s)
Adenosina Trifosfato/fisiología , Apoptosis/fisiología , Endotelio Vascular/fisiología , Hidrógeno/metabolismo , Mitocondrias/fisiología , Arteria Pulmonar/fisiología , Adenosina Trifosfato/deficiencia , Apoptosis/efectos de los fármacos , Calcio/metabolismo , Caspasa 3 , Caspasas/metabolismo , Células Cultivadas , Citosol/metabolismo , Fragmentación del ADN/fisiología , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Activación Enzimática , Inhibidores Enzimáticos/farmacología , Humanos , Concentración de Iones de Hidrógeno , Arteria Pulmonar/citología , Arteria Pulmonar/efectos de los fármacos , Estaurosporina/farmacología
5.
Pharmacol Res ; 22(3): 271-6, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2367278

RESUMEN

In the present study we have assayed antioxidant enzymatic systems in erythrocytes from subjects with chronic cerebrovascular disease to correlate their involvement in red cell deformability. A significant decrease of glutathione peroxidase, reductase, catalase and superoxide dismutase activities has been found in human red blood cells from patients with chronic cerebrovascular disease when compared to the control group. The decrease in antioxidant enzymatic systems found in these patients was accompanied by reduced cellular resistance to hydrogen peroxide. An altered balance between the partially reduced forms of oxygen metabolism and the antioxidant enzymatic systems could play a crucial role in the haemorheological alteration frequently occurring in subjects affected by chronic cerebrovascular disease.


Asunto(s)
Antioxidantes/análisis , Trastornos Cerebrovasculares/enzimología , Eritrocitos/enzimología , Anciano , Trastornos Cerebrovasculares/sangre , Enfermedad Crónica , Deformación Eritrocítica/fisiología , Glucosafosfato Deshidrogenasa/sangre , Glutatión Peroxidasa/sangre , Glutatión Reductasa/sangre , Humanos , Persona de Mediana Edad , Superóxido Dismutasa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...